Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

U.S. POC Study to Evaluate the Performance of the AcuVid COVID-19 Rapid Antigen Saliva Test

NCT05119530 is registered in ClinicalTrials.gov with Therma Bright Inc as lead sponsor.

NCT NCT05119530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05119530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
U.S. POC Study to Evaluate the Performance of the AcuVid COVID-19 Rapid Antigen Saliva Test
Lead sponsor
Therma Bright Inc
Phase
Observational
Overall status
Unknown status
Start date
December 6, 2021
Completion date
January 31, 2022
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19